SCHEMBL10276926

SCHEMBL10276926

NCC(=O)NCCCCCC(N)=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CASP2 P42575 1/20 0.45
SLC6A5 Q9Y345 2/20 0.44
PRMT1 Q99873 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NAAA Q02083 1/20 0.42
PAOX Q6QHF9 2/20 0.42
ADRA1A P35348 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
FAAH O00519 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21320655 0.98 MEN1 (0.44) ALDH1A1SMN1; SMN2CASP2SLC6A5PRMT1
SCHEMBL17177667 0.91 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2CASP2SLC6A5MEN1
SCHEMBL16556548 0.90 SLC6A5 (0.41) ALDH1A1SMN1; SMN2CASP2SLC6A5PRMT1
SCHEMBL20880558 0.90 SLC6A5 (0.41) ALDH1A1SMN1; SMN2CASP2SLC6A5PRMT1
SCHEMBL24611784 0.89 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2CASP2MEN1KMT2A
SCHEMBL14198854 0.89 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2CASP2MEN1KMT2A
SCHEMBL1940161 0.86 CASP2 (0.54) ALDH1A1SMN1; SMN2CASP2SLC6A5PRMT1
SCHEMBL16853212 0.86 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CASP2MEN1KMT2A
SCHEMBL8519057 0.85 PRMT1 (0.63) ALDH1A1SMN1; SMN2PRMT1MEN1KMT2A
SCHEMBL7436387 0.85 PRMT1 (0.63) ALDH1A1SMN1; SMN2PRMT1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765934-B2 Methods for conjugating nucleic acids with small molecules KAOHSIUNG MEDICAL UNIVERSITY (TW) 2014-07-01 US disclosed
US-20120177573-A1 METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120177573-A1 METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES RNGTT, POLM, POLRMT ALDH1A1 840/4885SMN1; SMN2 2853/4885CASP2 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.